Study Summary
This trial will use lower doses of radiation than usual to treat cancer, along with a drug called ALA that has been shown to be more effective in neoplastic cells. The goal is to create a treatment similar to photodynamic therapy that is safer for the patient.
- Solid Tumors
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 45 Days
Trial Safety
Safety Progress
Side Effects for
Trial Design
1 Treatment Group
5-ALA
1 of 1
Experimental Treatment
130 Total Participants · 1 Treatment Group
Primary Treatment: 5-ALA · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 20 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What other investigations have been conducted concerning 5-ALA?
"Currently, 18 studies investigating the effects of 5-ALA are underway with 2 reaching Phase 3. While these investigations have a major presence in Lebanon, New Hampshire, there is also data collection taking place across 56 other medical centres." - Anonymous Online Contributor
How many participants are being observed in this medical experiment?
"Affirmative. As documented on clinicaltrials.gov, this medical trial is actively recruiting individuals and had been first posted on July 30th 2020 with its most recent edit being August 10th 2022. Approximately 130 participants are needed from one site to complete the study's requirements." - Anonymous Online Contributor
Has the Food and Drug Administration endorsed 5-ALA for therapeutic use?
"As this is a Phase 1 trial, there is restricted data available to attest to the safety of 5-ALA; thus, our team at Power assigned it a score of 1." - Anonymous Online Contributor
How is 5-ALA regularly employed in medical treatment?
"5-ALA has been utilized to treat scalp structure, along with other ailments such as carcinoma, squamous cell carcinoma and facial conditions." - Anonymous Online Contributor
Are there vacancies in this research initiative for participants?
"Yes, the latest information from clinicaltrials.gov discloses that this medical investigation is actively recruiting participants. First launched on July 30th 2020 and recently modified on August 10th 2022, it seeks to enrol 130 patients at 1 trial centre." - Anonymous Online Contributor